| # | Drug | Count |
|---|---|---|
| 0 | NATALIZUMAB | 551 |
| 1 | INTERFERON BETA-1A | 486 |
| 2 | PREGABALIN | 368 |
| 3 | DALFAMPRIDINE | 304 |
| 4 | DIMETHYL FUMARATE | 292 |
| 5 | GABAPENTIN | 261 |
| 6 | ERGOCALCIFEROL | 250 |
| 7 | FINGOLIMOD HCL | 250 |
| 8 | PIMAVANSERIN TARTRATE | 224 |
| 9 | ASPIRIN | 202 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | 2 | 0.0098 |
| 1 | AXICABTAGENE CILOLEUCEL | 87 | 0.0086 |
| 2 | ERGOCALCIFEROL | 250 | 0.0084 |
| 3 | ETHACRYNIC ACID | 4 | 0.0072 |
| 4 | CUPRIC CHLORIDE | 5 | 0.0067 |
| 5 | VALPROATE SODIUM | 134 | 0.0064 |
| 6 | PSYLLIUM HUSK | 8 | 0.0059 |
| 7 | BREXUCABTAGENE AUTOLEUCEL | 12 | 0.0056 |
| 8 | DALFAMPRIDINE | 304 | 0.0042 |
| 9 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 2 | 0.0042 |
| # | Drug class | Count |
|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 558 |
| 1 | Benzodiazepine [EPC] | 511 |
| 2 | Interferon beta [EPC] | 507 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 505 |
| 4 | Potassium Channel Blocker [EPC] | 304 |
| 5 | Corticosteroid [EPC] | 300 |
| 6 | Provitamin D2 Compound [EPC] | 250 |
| 7 | Atypical Antipsychotic [EPC] | 219 |
| 8 | Vitamin C [EPC] | 216 |
| 9 | Proton Pump Inhibitor [EPC] | 213 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Chimeric Antigen Receptor [EPC] | 87 | 0.0086 |
| 1 | Provitamin D2 Compound [EPC] | 250 | 0.0084 |
| 2 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 15 | 0.0072 |
| 4 | Integrin Receptor Antagonist [EPC] | 558 | 0.0064 |
| 5 | Adrenocorticotropic Hormone [EPC] | 4 | 0.0045 |
| 6 | Potassium Channel Blocker [EPC] | 304 | 0.0042 |
| 7 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 5 | 0.0040 |
| 8 | Pyrimidine Synthesis Inhibitor [EPC] | 158 | 0.0035 |
| 9 | Catechol-O-Methyltransferase Inhibitor [EPC] | 17 | 0.0034 |